BMJ  2003;326 (31 May), doi:10.1136/bmj.326.7400.0

Research sponsored by drug companies is biased

Outcomes in research that is sponsored by a pharmaceutical company tend to favour the company's product. Lexchin and colleagues (p 1167) reviewed 30 studies that compared research sponsored by the drug industry and research that was funded in other ways. The quality of the methods was at least as good in research sponsored by industry as in research with other sources of funding, but industry sponsored studies were four times as likely to produce favourable outcomes. This might be due, the authors say, to an inappropriate comparator or to publication bias.

AGB/REX


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Joel Lexchin, Lisa A Bero, Benjamin Djulbegovic, and Otavio Clark
BMJ 2003 326: 1167-1170. [Abstract] [Full Text] [PDF]

Doctors and managers: Commission for Health Improvement gives its perspective
Linda Patterson and Nicholas L Bishop
BMJ 2003 326: 1214. [Extract] [Full Text]




Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview